prednisone,polatuzumab,rituximab,doxorubicin
roche,abbvie,biogen
['dlbcl', 'polarix', 'lymphoma']
the #cancerexpertnow team reports polarix trial analysis live from #asco22 a promising future treatment for poor-outcome-associated diffuse large b-cell lymphomas? pola-r-chp shows clinical benefit in patients who have bcl2+ and myc+ dlbcl. 
Real time, on-demand personalized cancer education and support through our online educational platform